nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—CYP2A6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0939	0.0939	CbGpPWpGaD
Rosiglitazone—CYP2A6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0824	0.0824	CbGpPWpGaD
Rosiglitazone—CYP2D6—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0527	0.0527	CbGpPWpGaD
Rosiglitazone—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0462	0.0462	CbGpPWpGaD
Rosiglitazone—CYP1A2—Fatty Acid Omega Oxidation—ADH7—pharynx cancer	0.0446	0.0446	CbGpPWpGaD
Rosiglitazone—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pharynx cancer	0.0391	0.0391	CbGpPWpGaD
Rosiglitazone—PTGS1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.028	0.028	CbGpPWpGaD
Rosiglitazone—CYP2A6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0265	0.0265	CbGpPWpGaD
Rosiglitazone—PTGS1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0245	0.0245	CbGpPWpGaD
Rosiglitazone—CYP2A6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0232	0.0232	CbGpPWpGaD
Rosiglitazone—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0181	0.0181	CbGpPWpGaD
Rosiglitazone—PTGS1—Biological oxidations—CNDP2—pharynx cancer	0.0164	0.0164	CbGpPWpGaD
Rosiglitazone—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0161	0.0161	CbGpPWpGaD
Rosiglitazone—CYP2A6—NRF2 pathway—ADH7—pharynx cancer	0.016	0.016	CbGpPWpGaD
Rosiglitazone—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0158	0.0158	CbGpPWpGaD
Rosiglitazone—CYP2A6—Biological oxidations—CNDP2—pharynx cancer	0.0155	0.0155	CbGpPWpGaD
Rosiglitazone—PTGS1—Biological oxidations—ADH7—pharynx cancer	0.0149	0.0149	CbGpPWpGaD
Rosiglitazone—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0148	0.0148	CbGpPWpGaD
Rosiglitazone—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0147	0.0147	CbGpPWpGaD
Rosiglitazone—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0141	0.0141	CbGpPWpGaD
Rosiglitazone—CYP2A6—Biological oxidations—ADH7—pharynx cancer	0.0141	0.0141	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—CNDP2—pharynx cancer	0.0131	0.0131	CbGpPWpGaD
Rosiglitazone—PTGS1—Biological oxidations—ADH1B—pharynx cancer	0.013	0.013	CbGpPWpGaD
Rosiglitazone—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.013	0.013	CbGpPWpGaD
Rosiglitazone—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0129	0.0129	CbGpPWpGaD
Rosiglitazone—CYP1A2—Phase II conjugation—CNDP2—pharynx cancer	0.0126	0.0126	CbGpPWpGaD
Rosiglitazone—CYP1A2—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0126	0.0126	CbGpPWpGaD
Rosiglitazone—CYP2A6—Biological oxidations—ADH1B—pharynx cancer	0.0123	0.0123	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—ADH7—pharynx cancer	0.0118	0.0118	CbGpPWpGaD
Rosiglitazone—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.011	0.011	CbGpPWpGaD
Rosiglitazone—CYP2C8—Biological oxidations—CNDP2—pharynx cancer	0.0106	0.0106	CbGpPWpGaD
Rosiglitazone—PPARG—Wnt Signaling Pathway Netpath—CCND1—pharynx cancer	0.0105	0.0105	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—ADH1B—pharynx cancer	0.0104	0.0104	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—B4GALT5—pharynx cancer	0.00991	0.00991	CbGpPWpGaD
Rosiglitazone—CYP2C8—Biological oxidations—ADH7—pharynx cancer	0.0096	0.0096	CbGpPWpGaD
Rosiglitazone—CYP2C19—Biological oxidations—CNDP2—pharynx cancer	0.00947	0.00947	CbGpPWpGaD
Rosiglitazone—CYP2D6—Biological oxidations—CNDP2—pharynx cancer	0.00871	0.00871	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of retinoblastoma protein—CCND1—pharynx cancer	0.0087	0.0087	CbGpPWpGaD
Rosiglitazone—CYP2C9—Biological oxidations—CNDP2—pharynx cancer	0.00864	0.00864	CbGpPWpGaD
Rosiglitazone—CYP2C19—Biological oxidations—ADH7—pharynx cancer	0.00857	0.00857	CbGpPWpGaD
Rosiglitazone—CYP2C8—Biological oxidations—ADH1B—pharynx cancer	0.00842	0.00842	CbGpPWpGaD
Rosiglitazone—CYP2D6—Biological oxidations—ADH7—pharynx cancer	0.00788	0.00788	CbGpPWpGaD
Rosiglitazone—CYP2C9—Biological oxidations—ADH7—pharynx cancer	0.00781	0.00781	CbGpPWpGaD
Rosiglitazone—CYP2C19—Biological oxidations—ADH1B—pharynx cancer	0.00751	0.00751	CbGpPWpGaD
Rosiglitazone—CYP1A2—Biological oxidations—CNDP2—pharynx cancer	0.00738	0.00738	CbGpPWpGaD
Rosiglitazone—CYP2D6—Biological oxidations—ADH1B—pharynx cancer	0.00691	0.00691	CbGpPWpGaD
Rosiglitazone—CYP2C9—Biological oxidations—ADH1B—pharynx cancer	0.00685	0.00685	CbGpPWpGaD
Rosiglitazone—CYP1A2—Biological oxidations—ADH7—pharynx cancer	0.00668	0.00668	CbGpPWpGaD
Rosiglitazone—CYP2A6—Fluoropyrimidine Activity—TP53—pharynx cancer	0.00661	0.00661	CbGpPWpGaD
Rosiglitazone—CYP1A2—Biological oxidations—ADH1B—pharynx cancer	0.00585	0.00585	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CNDP2—pharynx cancer	0.00401	0.00401	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ADH7—pharynx cancer	0.00363	0.00363	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ADH1B—pharynx cancer	0.00318	0.00318	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CNDP2—pharynx cancer	0.00316	0.00316	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—B4GALT5—pharynx cancer	0.00304	0.00304	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00287	0.00287	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pharynx cancer	0.00287	0.00287	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ADH7—pharynx cancer	0.00286	0.00286	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CNDP2—pharynx cancer	0.00281	0.00281	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CNDP2—pharynx cancer	0.00266	0.00266	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—TP53—pharynx cancer	0.00258	0.00258	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ADH7—pharynx cancer	0.00254	0.00254	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ADH1B—pharynx cancer	0.0025	0.0025	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ADH7—pharynx cancer	0.0024	0.0024	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—B4GALT5—pharynx cancer	0.00239	0.00239	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—TP53—pharynx cancer	0.00235	0.00235	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ADH1B—pharynx cancer	0.00223	0.00223	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—B4GALT5—pharynx cancer	0.00213	0.00213	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ADH1B—pharynx cancer	0.00211	0.00211	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—B4GALT5—pharynx cancer	0.00201	0.00201	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.00182	0.00182	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CNDP2—pharynx cancer	0.0018	0.0018	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ADH7—pharynx cancer	0.00164	0.00164	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ADH7—pharynx cancer	0.00163	0.00163	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CNDP2—pharynx cancer	0.00162	0.00162	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.00149	0.00149	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CNDP2—pharynx cancer	0.00148	0.00148	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ADH7—pharynx cancer	0.00147	0.00147	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.00144	0.00144	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ADH1B—pharynx cancer	0.00143	0.00143	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.00138	0.00138	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—B4GALT5—pharynx cancer	0.00137	0.00137	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—EGFR—pharynx cancer	0.00136	0.00136	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ADH7—pharynx cancer	0.00135	0.00135	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ADH7—pharynx cancer	0.00134	0.00134	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ADH1B—pharynx cancer	0.00128	0.00128	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CNDP2—pharynx cancer	0.00126	0.00126	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—B4GALT5—pharynx cancer	0.00123	0.00123	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.00118	0.00118	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ADH1B—pharynx cancer	0.00117	0.00117	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ADH7—pharynx cancer	0.00114	0.00114	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.00113	0.00113	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—B4GALT5—pharynx cancer	0.00112	0.00112	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ADH1B—pharynx cancer	0.001	0.001	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—B4GALT5—pharynx cancer	0.000957	0.000957	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—pharynx cancer	0.000506	0.000506	CbGpPWpGaD
